SIRT3 and metabolic dysfunction-associated steatohepatitis: Conversely, overexpression of SIRT3 results in opposite effects suggesting that SIRT3 ablation aggravates MCD induced NASH while SIRT3 overexpression alleviates the MCD induced phenotype [162].